Toll Free: 1-888-928-9744

Global and China Biologics and Biosimilars Sales Market Report 2020

Published: Jul 11, 2016 | Pages: 124 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report studies Biologics and Biosimilars in Global and China market, focuses on top manufacturers in global and China market, involving Biologics and Biosimilars price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Biologics and Biosimilars in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011.

Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering
    Antibody
    Hormone
    Growth Factors
    Other
Split by manufacturers, this report focuses on the production, price of each type, average price of Biologics and Biosimilars, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck
    3sbio
    Changchun High Tech
    CP Guojian
    Biotech
    Gelgen
    Innovent
    Dong Bao
    Ganlee
    United Laboratories

Split by applications, this report focuses on consumption and growth rate of Biologics and Biosimilars in each application, can be divided into
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

Split by regions, this report focuses on the production, revenue, consumption and market share of Biologics and Biosimilars in these regions, from 2011 to 2020 (forecast), covering
    USA
    EU
    Japan
    China
    India 
    Southeast Asia

 Table of Contents
Global and China Biologics and Biosimilars Research Report to 2020 1 Biologics and Biosimilars Overview and Price of Each Type 1.1 Product Overview and Scope of Biologics and Biosimilars 1.2 Global and China Biologics and Biosimilars Production, Growth Rate 2011 to 2020 1.3 Global and China Biologics and Biosimilars Revenue, Growth Rate 2011 to 2020 1.4 Product Segments and Price of Each Type 1.4.1 Antibody and Price List (2015-2016) 1.4.2 Hormone and Price List (2015-2016) 1.4.3 Growth Factors and Price List (2015-2016) 1.4.4 Other and Price List (2015-2016) 1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016 1.5.1 Price List (Interviewed) of Antibody by Key Manufacturers 1.5.2 Price List (Interviewed) of Hormone by Key Manufacturers 1.5.3 Price List (Interviewed) of Growth Factors by Key Manufacturers 1.5.4 Price List (Interviewed) of Other by Key Manufacturers 1.6 Global and China Biologics and Biosimilars Market Share by Type in 2015 1.6.1 Global Biologics and Biosimilars Market Share by Type in 2015 1.6.2 China Biologics and Biosimilars Market Share by Type in 2015 2 Global and China Market Competition Analysis by Manufacturers 2.1 Global Market Biologics and Biosimilars Production, Revenue and Share List of Key Manufacturers 2015 to 2016 2.1.1 Global Market Biologics and Biosimilars Production and Share of Key Manufacturers 2015 to 2016 2.1.2 Global Market Biologics and Biosimilars Revenue and Share of Key Manufacturers 2015 to 2016 2.1.3 Global Market Biologics and Biosimilars Average Price of Key Manufacturers 2015 to 2016 2.2 China Market Biologics and Biosimilars Production, Revenue and Share of Key Manufacturers 2015 to 2016 2.2.1 China Market Biologics and Biosimilars Production and Share of Key Manufacturers 2015 to 2016 2.2.2 China Market Biologics and Biosimilars Revenue and Share of Key Manufacturers 2015 to 2016 2.3 Global Biologics and Biosimilars Manufacturing Base Distribution and Product Type of each Manufacturer 3 Global and China Biologics and Biosimilars Production, Revenue and Growth Rate by Type 3.1 Global Biologics and Biosimilars Production, Revenue and Growth Rate by Type (2011-2020) 3.1.1 Global Biologics and Biosimilars Production and Market Share by Type (2011-2020) 3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2020) 3.1.3 Global Biologics and Biosimilars Price by Type (2011-2020) 3.2 Global Biologics and Biosimilars Production Growth Rate by Type (2011-2020) 3.2.1 Antibody Production and Production Growth Rate 2011-2020 3.2.2 Hormone Production and Production Growth Rate 2011-2020 3.2.3 Growth Factors Production and Production Growth Rate 2011-2020 3.2.4 Other Production and Production Growth Rate 2011-2020 3.3 China Biologics and Biosimilars Production, Revenue and Growth Rate by Type (2011-2020) 3.3.1 China Biologics and Biosimilars Production and Market Share by Type (2011-2020) 3.3.4 China Biologics and Biosimilars Revenue and Market Share by Type (2011-2020) 3.3.3 China Biologics and Biosimilars Price by Type (2011-2020) 3.4 China Biologics and Biosimilars Production Growth Rate by Type (2011-2020) 3.4.1 Antibody Production and Production Growth Rate 2011-2020 3.4.2 Hormone Production and Production Growth Rate 2011-2020 3.4.3 Growth Factors Production and Production Growth Rate 2011-2020 3.4.4 Other Production and Production Growth Rate 2011-2020 4 Global and China Biologics and Biosimilars Key Manufacturers Analysis 4.1 Roche 4.1.1 Company Basic Information, Manufacturing Base and Competitors 4.1.2 Biologics and Biosimilars Product Segment of Roche by Type 4.1.2.1 Antibody and Price in 2015 and 2016 of Roche 4.1.2.2 Hormone and Price in 2015 and 2016 of Roche 4.1.2.3 Growth Factors and Price in 2015 and 2016 of Roche 4.1.3 Biologics and Biosimilars Production, Revenue, Price of Roche 2015 to 2016 4.1.4 Interviewee, Name and Contact 4.2 Amgen 4.2.1 Company Basic Information, Manufacturing Base and Competitors 4.2.2 Biologics and Biosimilars Product Segment of Amgen by Type 4.2.2.1 Antibody and Price in 2015 and 2016 of Amgen 4.2.2.2 Hormone and Price in 2015 and 2016 of Amgen 4.2.2.3 Growth Factors and Price in 2015 and 2016 of Amgen 4.2.3 Biologics and Biosimilars Production, Revenue, Price of Amgen 2015 to 2016 4.2.4 Interviewee, Name and Contact 4.3 AbbVie 4.3.1 Company Basic Information, Manufacturing Base and Competitors 4.3.2 Biologics and Biosimilars Product Segment of AbbVie by Type 4.3.2.1 Antibody and Price in 2015 and 2016 of AbbVie 4.3.2.2 Hormone and Price in 2015 and 2016 of AbbVie 4.3.2.3 Growth Factors and Price in 2015 and 2016 of AbbVie 4.3.3 Biologics and Biosimilars Production, Revenue, Price of AbbVie 2015 to 2016 4.3.4 Interviewee, Name and Contact 4.4 Sanofi-Aventis 4.4.1 Company Basic Information, Manufacturing Base and Competitors 4.4.2 Biologics and Biosimilars Product Segment of Sanofi-Aventis by Type 4.4.2.1 Antibody and Price in 2015 and 2016 of Sanofi-Aventis 4.4.2.2 Hormone and Price in 2015 and 2016 of Sanofi-Aventis 4.4.2.3 Growth Factors and Price in 2015 and 2016 of Sanofi-Aventis 4.4.3 Biologics and Biosimilars Production, Revenue, Price of Sanofi-Aventis 2015 to 2016 4.4.4 Interviewee, Name and Contact 4.5 Johnson & Johnson 4.5.1 Company Basic Information, Manufacturing Base and Competitors 4.5.2 Biologics and Biosimilars Product Segment of Johnson & Johnson by Type 4.5.2.1 Antibody and Price in 2015 and 2016 of Johnson & Johnson 4.5.2.2 Hormone and Price in 2015 and 2016 of Johnson & Johnson 4.5.2.3 Growth Factors and Price in 2015 and 2016 of Johnson & Johnson 4.5.3 Biologics and Biosimilars Production, Revenue, Price of Johnson & Johnson 2015 to 2016 4.5.4 Interviewee, Name and Contact 4.6 Pfizer 4.6.1 Company Basic Information, Manufacturing Base and Competitors 4.6.2 Biologics and Biosimilars Product Segment of Pfizer by Type 4.6.2.1 Antibody and Price in 2016 and 2016 of Pfizer 4.6.2.2 Hormone and Price in 2016 and 2016 of Pfizer 4.6.2.3 Growth Factors and Price in 2016 and 2016 of Pfizer 4.6.3 Biologics and Biosimilars Production, Revenue, Price of Pfizer 2016 to 2016 4.6.4 Interviewee, Name and Contact 4.7 Novo Nordisk 4.7.1 Company Basic Information, Manufacturing Base and Competitors 4.7.2 Biologics and Biosimilars Product Segment of Novo Nordisk by Type 4.7.2.1 Antibody and Price in 2017 and 2017 of Novo Nordisk 4.7.2.2 Hormone and Price in 2017 and 2017 of Novo Nordisk 4.7.2.3 Growth Factors and Price in 2017 and 2017 of Novo Nordisk 4.7.3 Biologics and Biosimilars Production, Revenue, Price of Novo Nordisk 2017 to 2017 4.7.4 Interviewee, Name and Contact 4.8 Eli Lilly 4.8.1 Company Basic Information, Manufacturing Base and Competitors 4.8.2 Biologics and Biosimilars Product Segment of Eli Lilly by Type 4.8.2.1 Antibody and Price in 2018 and 2018 of Eli Lilly 4.8.2.2 Hormone and Price in 2018 and 2018 of Eli Lilly 4.8.2.3 Growth Factors and Price in 2018 and 2018 of Eli Lilly 4.8.3 Biologics and Biosimilars Production, Revenue, Price of Eli Lilly 2018 to 2018 4.8.4 Interviewee, Name and Contact 4.9 Novartis 4.9.1 Company Basic Information, Manufacturing Base and Competitors 4.9.2 Biologics and Biosimilars Product Segment of Novartis by Type 4.9.2.1 Antibody and Price in 2019 and 2019 of Novartis 4.9.2.2 Hormone and Price in 2019 and 2019 of Novartis 4.9.2.3 Growth Factors and Price in 2019 and 2019 of Novartis 4.9.3 Biologics and Biosimilars Production, Revenue, Price of Novartis 2019 to 2019 4.9.4 Interviewee, Name and Contact 4.10 Merck 4.10.1 Company Basic Information, Manufacturing Base and Competitors 4.10.2 Biologics and Biosimilars Product Segment of Merck by Type 4.10.2.1 Antibody and Price in 2020 and 2020 of Merck 4.10.2.2 Hormone and Price in 2020 and 2020 of Merck 4.10.2.3 Growth Factors and Price in 2020 and 2020 of Merck 4.10.3 Biologics and Biosimilars Production, Revenue, Price of Merck 2020 to 2020 4.10.4 Interviewee, Name and Contact 4.11 3sbio 4.11.1 Company Basic Information, Manufacturing Base and Competitors 4.11.2 Biologics and Biosimilars Product Segment of 3sbio by Type 4.11.2.1 Antibody and Price in 2021 and 2021 of 3sbio 4.11.2.2 Hormone and Price in 2021 and 2021 of 3sbio 4.11.2.3 Growth Factors and Price in 2021 and 2021 of 3sbio 4.11.3 Biologics and Biosimilars Production, Revenue, Price of 3sbio 2021 to 2021 4.11.4 Interviewee, Name and Contact 4.12 Changchun High Tech 4.12.1 Company Basic Information, Manufacturing Base and Competitors 4.12.2 Biologics and Biosimilars Product Segment of Changchun High Tech by Type 4.12.2.1 Antibody and Price in 2022 and 2022 of Changchun High Tech 4.12.2.2 Hormone and Price in 2022 and 2022 of Changchun High Tech 4.12.2.3 Growth Factors and Price in 2022 and 2022 of Changchun High Tech 4.12.3 Biologics and Biosimilars Production, Revenue, Price of Changchun High Tech 2022 to 2022 4.12.4 Interviewee, Name and Contact 4.13 CP Guojian 4.13.1 Company Basic Information, Manufacturing Base and Competitors 4.13.2 Biologics and Biosimilars Product Segment of CP Guojian by Type 4.13.2.1 Antibody and Price in 2023 and 2023 of CP Guojian 4.13.2.2 Hormone and Price in 2023 and 2023 of CP Guojian 4.13.2.3 Growth Factors and Price in 2023 and 2023 of CP Guojian 4.13.3 Biologics and Biosimilars Production, Revenue, Price of CP Guojian 2023 to 2023 4.13.4 Interviewee, Name and Contact 4.14 Biotech 4.14.1 Company Basic Information, Manufacturing Base and Competitors 4.14.2 Biologics and Biosimilars Product Segment of Biotech by Type 4.14.2.1 Antibody and Price in 2024 and 2024 of Biotech 4.14.2.2 Hormone and Price in 2024 and 2024 of Biotech 4.14.2.3 Growth Factors and Price in 2024 and 2024 of Biotech 4.14.3 Biologics and Biosimilars Production, Revenue, Price of Biotech 2024 to 2024 4.14.4 Interviewee, Name and Contact 4.15 Gelgen 4.15.1 Company Basic Information, Manufacturing Base and Competitors 4.15.2 Biologics and Biosimilars Product Segment of Gelgen by Type 4.15.2.1 Antibody and Price in 2025 and 2025 of Gelgen 4.15.2.2 Hormone and Price in 2025 and 2025 of Gelgen 4.15.2.3 Growth Factors and Price in 2025 and 2025 of Gelgen 4.15.3 Biologics and Biosimilars Production, Revenue, Price of Gelgen 2025 to 2025 4.15.4 Interviewee, Name and Contact 4.16 Innovent 4.16.1 Company Basic Information, Manufacturing Base and Competitors 4.16.2 Biologics and Biosimilars Product Segment of Innovent by Type 4.16.2.1 Antibody and Price in 2026 and 2026 of Innovent 4.16.2.2 Hormone and Price in 2026 and 2026 of Innovent 4.16.2.3 Growth Factors and Price in 2026 and 2026 of Innovent 4.16.3 Biologics and Biosimilars Production, Revenue, Price of Innovent 2026 to 2026 4.16.4 Interviewee, Name and Contact 4.17 Dong Bao 4.17.1 Company Basic Information, Manufacturing Base and Competitors 4.17.2 Biologics and Biosimilars Product Segment of Dong Bao by Type 4.17.2.1 Antibody and Price in 2027 and 2027 of Dong Bao 4.17.2.2 Hormone and Price in 2027 and 2027 of Dong Bao 4.17.2.3 Growth Factors and Price in 2027 and 2027 of Dong Bao 4.17.3 Biologics and Biosimilars Production, Revenue, Price of Dong Bao 2027 to 2027 4.17.4 Interviewee, Name and Contact 4.18 Ganlee 4.18.1 Company Basic Information, Manufacturing Base and Competitors 4.18.2 Biologics and Biosimilars Product Segment of Ganlee by Type 4.18.2.1 Antibody and Price in 2028 and 2028 of Ganlee 4.18.2.2 Hormone and Price in 2028 and 2028 of Ganlee 4.18.2.3 Growth Factors and Price in 2028 and 2028 of Ganlee 4.18.3 Biologics and Biosimilars Production, Revenue, Price of Ganlee 2028 to 2028 4.18.4 Interviewee, Name and Contact 4.19 United Laboratories 4.19.1 Company Basic Information, Manufacturing Base and Competitors 4.19.2 Biologics and Biosimilars Product Segment of United Laboratories by Type 4.19.2.1 Antibody and Price in 2029 and 2029 of United Laboratories 4.19.2.2 Hormone and Price in 2029 and 2029 of United Laboratories 4.19.2.3 Growth Factors and Price in 2029 and 2029 of United Laboratories 4.19.3 Biologics and Biosimilars Production, Revenue, Price of United Laboratories 2029 to 2029 4.19.4 Interviewee, Name and Contact 5 Global Biologics and Biosimilars Production by Regions 2011-2020 5.1 Global Biologics and Biosimilars Production and Revenue by Regions 2011-2020 5.1.1 Global Biologics and Biosimilars Production by Regions 2011-2020 5.1.2 Global Biologics and Biosimilars Revenue by Regions 2011-2020 5.2 China Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020 5.3 USA Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020 5.4 EU Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020 5.5 Japan Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020 5.6 Southeast Asia Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020 5.7 India Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020 6 Global Biologics and Biosimilars Consumption by Regions 2011-2020 6.1 Global Biologics and Biosimilars Consumption by Regions 2011-2020 6.2 China Biologics and Biosimilars Consumption Growth Rate 2011-2020 6.3 USA Biologics and Biosimilars Consumption Growth Rate 2011-2020 6.4 EU Biologics and Biosimilars Consumption Growth Rate 2011-2020 6.5 Japan Biologics and Biosimilars Consumption Growth Rate 2011-2020 6.6 Southeast Asia Biologics and Biosimilars Consumption Growth Rate 2011-2020 6.7 India Biologics and Biosimilars Consumption Growth Rate 2011-2020 7 Global Biologics and Biosimilars Analysis by Application and Client (Buyers) 7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020 7.2 Tumor 7.2.1 Tumor Analysis 7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Tumor 7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020 7.2 Diabetes 7.2.1 Diabetes Analysis 7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Diabetes 7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020 7.2 Cardiovascular 7.2.1 Cardiovascular Analysis 7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Cardiovascular 7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020 7.2 Hemophilia 7.2.1 Hemophilia Analysis 7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Hemophilia 7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020 7.2 Other 7.2.1 Other Analysis 7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Other 8 Biologics and Biosimilars Technology and Development Trend 8.1 Biologics and Biosimilars Technology Analysis 8.1.1 Global Biologics and Biosimilars Technology 8.1.2 China Biologics and Biosimilars Technology 8.2 Biologics and Biosimilars Technology Development Trend Analysis 8.2.1 Global Biologics and Biosimilars Technology Development Trend 8.2.2 China Biologics and Biosimilars Technology Development Trend 9 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Biologics and Biosimilars Figure Global Biologics and Biosimilars Production and Growth Rate 2011 to 2020 Figure China Biologics and Biosimilars Production and Growth Rate 2011 to 2020 Figure Global Biologics and Biosimilars Revenue and Growth Rate 2011 to 2020 Figure China Biologics and Biosimilars Revenue and Growth Rate 2011 to 2020 Figure Picture of Antibody Figure Picture of Hormone Figure Picture of Growth Factors Figure Picture of Other Table Price List (Interviewed) of Antibody by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Hormone by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Growth Factors by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Other by Key Manufacturers in 2015 and 2016 Figure Global Biologics and Biosimilars Market Share by Type in 2015 Figure China Biologics and Biosimilars Market Share by Type in 2015 Table Global Market Biologics and Biosimilars Production of Key Manufacturers 2015 to 2016 Table Global Market Biologics and Biosimilars Production Share of Key Manufacturers 2015 to 2016 Table Global Market Biologics and Biosimilars Revenue of Key Manufacturers 2015 to 2016 Table Global Market Biologics and Biosimilars Revenue Share of Key Manufacturers 2015 to 2016 Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers 2015 to 2016 Table China Market Biologics and Biosimilars Production of Key Manufacturers 2015 to 2016 Table China Market Biologics and Biosimilars Production Share of Key Manufacturers 2015 to 2016 Table China Market Biologics and Biosimilars Revenue of Key Manufacturers 2015 to 2016 Table China Market Biologics and Biosimilars Revenue Share of Key Manufacturers 2015 to 2016 Table Global Biologics and Biosimilars Manufacturing Base Distribution and Product Type of each Manufacturer Table Global Biologics and Biosimilars Production by Type (2011-2020) Table Global Biologics and Biosimilars Production Market Share by Type (2011-2020) Table Global Biologics and Biosimilars Revenue by Type (2011-2020) Table Global Biologics and Biosimilars Revenue Market Share by Type (2011-2020) Figure Global Biologics and Biosimilars Price by Type (2011-2020) Figure Antibody Production and Production Growth Rate 2011-2020 Figure Hormone Production and Production Growth Rate 2011-2020 Figure Growth Factors Production and Production Growth Rate 2011-2020 Figure Other Production and Production Growth Rate 2011-2020 Table China Biologics and Biosimilars Production by Type (2011-2020) Table China Biologics and Biosimilars Production Market Share by Type (2011-2020) Table China Biologics and Biosimilars Revenue by Type (2011-2020) Table China Biologics and Biosimilars Revenue Market Share by Type (2011-2020) Figure China Biologics and Biosimilars Price by Type (2011-2020) Figure Antibody Production and Production Growth Rate 2011-2020 Figure Hormone Production and Production Growth Rate 2011-2020 Figure Growth Factors Production and Production Growth Rate 2011-2020 Figure Other Production and Production Growth Rate 2011-2020 Table Roche Basic Information List Table Antibody and Price in 2015 and 2016 of Roche Table Hormone and Price in 2015 and 2016 of Roche Table Growth Factors and Price in 2015 and 2016 of Roche Table Biologics and Biosimilars Production, Revenue, Price of Roche 2015 to 2016 Table Amgen Basic Information List Table Antibody and Price in 2015 and 2016 of Amgen Table Hormone and Price in 2015 and 2016 of Amgen Table Growth Factors and Price in 2015 and 2016 of Amgen Table Biologics and Biosimilars Production, Revenue, Price of Amgen 2015 to 2016 Table AbbVie Basic Information List Table Antibody and Price in 2015 and 2016 of AbbVie Table Hormone and Price in 2015 and 2016 of AbbVie Table Growth Factors and Price in 2015 and 2016 of AbbVie Table Biologics and Biosimilars Production, Revenue, Price of AbbVie 2015 to 2016 Table Sanofi-Aventis Basic Information List Table Antibody and Price in 2015 and 2016 of Sanofi-Aventis Table Hormone and Price in 2015 and 2016 of Sanofi-Aventis Table Growth Factors and Price in 2015 and 2016 of Sanofi-Aventis Table Biologics and Biosimilars Production, Revenue, Price of Sanofi-Aventis 2015 to 2016 Table Johnson & Johnson Basic Information List Table Antibody and Price in 2015 and 2016 of Johnson & Johnson Table Hormone and Price in 2015 and 2016 of Johnson & Johnson Table Growth Factors and Price in 2015 and 2016 of Johnson & Johnson Table Biologics and Biosimilars Production, Revenue, Price of Johnson & Johnson 2015 to 2016 Table Pfizer Basic Information List Table Antibody and Price in 2015 and 2016 of Pfizer Table Hormone and Price in 2015 and 2016 of Pfizer Table Growth Factors and Price in 2015 and 2016 of Pfizer Table Biologics and Biosimilars Production, Revenue, Price of Pfizer 2015 to 2016 Table Novo Nordisk Basic Information List Table Antibody and Price in 2015 and 2016 of Novo Nordisk Table Hormone and Price in 2015 and 2016 of Novo Nordisk Table Growth Factors and Price in 2015 and 2016 of Novo Nordisk Table Biologics and Biosimilars Production, Revenue, Price of Novo Nordisk 2015 to 2016 Table Eli Lilly Basic Information List Table Antibody and Price in 2015 and 2016 of Eli Lilly Table Hormone and Price in 2015 and 2016 of Eli Lilly Table Growth Factors and Price in 2015 and 2016 of Eli Lilly Table Biologics and Biosimilars Production, Revenue, Price of Eli Lilly 2015 to 2016 Table Novartis Basic Information List Table Antibody and Price in 2015 and 2016 of Novartis Table Hormone and Price in 2015 and 2016 of Novartis Table Growth Factors and Price in 2015 and 2016 of Novartis Table Biologics and Biosimilars Production, Revenue, Price of Novartis 2015 to 2016 Table Merck Basic Information List Table Antibody and Price in 2015 and 2016 of Merck Table Hormone and Price in 2015 and 2016 of Merck Table Growth Factors and Price in 2015 and 2016 of Merck Table Biologics and Biosimilars Production, Revenue, Price of Merck 2015 to 2016 Table 3sbio Basic Information List Table Antibody and Price in 2015 and 2016 of 3sbio Table Hormone and Price in 2015 and 2016 of 3sbio Table Growth Factors and Price in 2015 and 2016 of 3sbio Table Biologics and Biosimilars Production, Revenue, Price of 3sbio 2015 to 2016 Table Global Biologics and Biosimilars Production by Regions 2011-2020 Table Global Biologics and Biosimilars Production Share by Regions 2011-2020 Table Global Biologics and Biosimilars Revenue by Regions 2011-2020 Table Global Biologics and Biosimilars Revenue Share by Regions 2011-2020 Figure China Biologics and Biosimilars Production Growth Rate 2011-2020 Figure China Biologics and Biosimilars Revenue Growth Rate 2011-2020 Figure USA Biologics and Biosimilars Production Growth Rate 2011-2020 Figure USA Biologics and Biosimilars Revenue Growth Rate 2011-2020 Figure EU Biologics and Biosimilars Production Growth Rate 2011-2020 Figure EU Biologics and Biosimilars Revenue Growth Rate 2011-2020 Figure Japan Biologics and Biosimilars Production Growth Rate 2011-2020 Figure Japan Biologics and Biosimilars Revenue Growth Rate 2011-2020 Figure Southeast Asia Biologics and Biosimilars Production Growth Rate 2011-2020 Figure Southeast Asia Biologics and Biosimilars Revenue Growth Rate 2011-2020 Figure India Biologics and Biosimilars Production Growth Rate 2011-2020 Figure India Biologics and Biosimilars Revenue Growth Rate 2011-2020 Table Global Biologics and Biosimilars Consumption by Regions 2011-2020 Table Global Biologics and Biosimilars Consumption Share by Regions 2011-2020 Figure China Biologics and Biosimilars Consumption Growth Rate 2011-2020 Figure USA Biologics and Biosimilars Consumption Growth Rate 2011-2020 Figure EU Biologics and Biosimilars Production Growth Rate 2011-2020 Figure Japan Biologics and Biosimilars Consumption Growth Rate 2011-2020 Figure Southeast Asia Biologics and Biosimilars Consumption Growth Rate 2011-2020 Figure India Biologics and Biosimilars Consumption Growth Rate 2011-2020 Table Global Biologics and Biosimilars Consumption by Application 2011-2020 Table Global Biologics and Biosimilars Consumption Market Share by Application 2011-2020 Figure Tumor Biologics and Biosimilars Consumption and Growth Rate 2011-2020 Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Tumor Figure Diabetes Biologics and Biosimilars Consumption and Growth Rate 2011-2020 Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Diabetes Figure Cardiovascular Biologics and Biosimilars Consumption and Growth Rate 2011-2020 Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Cardiovascular Figure Hemophilia Biologics and Biosimilars Consumption and Growth Rate 2011-2020 Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Hemophilia



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...
Choose License Type
Single User - US $2900
Multi User - US $5800
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify